- Dalfopristin
-
Dalfopristin Systematic (IUPAC) name (3R,4R,5E,10E,12E,14S,26R,26aS)-26-[[2-(diethylamino)ethyl]sulfonyl]-8,9,14,15,24,25,26,26a- octahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]-dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone Clinical data AHFS/Drugs.com International Drug Names MedlinePlus a603007 Pregnancy cat. ? Legal status ? Pharmacokinetic data Half-life 1 hour Identifiers CAS number 112362-50-2 ATC code None PubChem CID 6435782 DrugBank DB01764 ChemSpider 4940480 UNII R9M4FJE48E KEGG D00853 ChEMBL CHEMBL1200937 Chemical data Formula C34H50N4O9S Mol. mass 690.85 g/mol (what is this?) (verify) Dalfopristin is a streptogramin antibiotic derived from pristinamycin IIA. The combination quinupristin/dalfopristin, in a weight-to-weight ratio of 30% quinupristin to 70% dalfopristin, is used to treat infections by staphylococci and by vancomycin-resistant Enterococcus faecium.[1]
References
- ^ Allington DR, Rivey MP (2001). "Quinupristin/dalfopristin: a therapeutic review". Clin Ther 23 (1): 24–44. doi:10.1016/S0149-2918(01)80028-X. PMID 11219478.
This pharmacology-related article is a stub. You can help Wikipedia by expanding it.